Lithotripsy for kidney stones

Series
Nephrology and Urology
Status
Published
Date
Number of report
087

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for lithotripsy for kidney stones in Europe.

The following types of procedure will be considered:

  • Extraorporeal shock wave therapy;
  • Intracorporeal (endoscopic) lithotripsy with different type of energy used.

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • England (UK)
  • Finland
  • France
  • Germany
  • Hungary
  • Italy
  • The Netherlands
  • Norway
  • Romania
  • Russia
  • Sweden
  • Switzerland
  • Turkey

Manufacturers devices of lithotripsy for kidney stones include:

  • Allengers (Urolith+, Blaze)
  • Apex-MediTech (LITHOSPLIT - 4.1 DIGITAL, LITHOSPLIT - 4)
  • Boston Scientific (Auriga XL, LithoClast)
  • Coloplast (Dormia, Biosoft, Vortek, ReTrace, Dormia No-Tip, Detour, In-Ka, Vortek)
  • C.R. Bard (Solo Plus, X-FORCE, SkyLite, INLAY OPTIMA, ProFlex)
  • Direx Group (Duet Magna)
  • Dornier MedTech (Dornier Delta, Dornier Medilas, Dornier Compact Sigma, Dornier Compact Delta, Dornier Aries, Dornier Medilas)
  • EDAP TMS (Sonolith i-sys, Sonolith i-move)
  • Electro Medical Systems (Lithoclast Trilogy, All-In-One, Lithoclast Master, Laserclast, LithoClast 2, LithoBreaker, LithoPump)
  • Lumenis (Moses Pulse, VersaPilse)
  • Medispec (Lithospec, E2000, E3000, EM1000)
  • MTS medical (Lithogold380)
  • Olympus (Empower, Nitinol Baskets, Ultra-Catch, ShockPulse)
  • Richard Wolf (PiezoLith 3000Plus, PiezoLith 3000)
  • Storz Medical (MODULITH SLX-F2, MODULITH SLK)
  • Walz Elektronik (Lithotron EL)

Table of content is not available at the moment. Report is still ongoing.

21

Oct 2019

MTRC has developed three reports on the key market access topics, including innovation funding, health technology assessment and funding frameworks for medical devices. These reports help to understand the relevance of these frameworks to certain types of medical technologies, including nephrology and urology technologies. This post provides some key facts about the HTA, funding and innovation payment landscape for nephrology and urology devices in Europe.

Read more

17

Oct 2019

The report presents a summary of the reimbursement situation for lithotripsy for kidney stones in Europe. The following types of procedure are considered: extracorporeal shock wave therapy; intracorporeal (endoscopic) lithotripsy with different type of energy used. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more

06

Aug 2019

The report presents a summary of the reimbursement situation for peritoneal dialysis in chronic renal failure in Europe. The analysis covers adult patients only. The haemodialysis procedure are considered in the end-stage chronic renal failure. The only reimbursement within public / statutory health insurance systems is considered. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more

06

Aug 2019

The report presents a summary of the reimbursement situation for use of hemodialysis as out-patient session treatment for chronic renal in Europe. The analysis covers adult patients only. The haemodialysis procedure are considered in the end-stage chronic renal failure. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more

06

Aug 2019

The report presents a summary of the reimbursement situation for use of hemodialysis as treatment for acute kidney injury in Europe. The analysis covers adult patients only. The only reimbursement within public / statutory health insurance systems is considered. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more
(we accept only company emails)